December 9, 2022 โ Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...
December 8, 2022 โ Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of ...
December 8, 2022 โ The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
December 8, 2022 โ Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...
December 8, 2022 โ Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...
December 7, 2022 โ While heart disease is a leading cause of death in the United States, most people can be treated with ...
SPONSORED CONTENT โ Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
December 7, 2022 โ Compared with team-based care alone, the addition of a computerized clinical decision support system ...
December 7, 2022 โ BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
December 7, 2022 โ Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 5, 2022 โ Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the ...
December 5, 2022 โ The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...
Here is a recap of what DAIC viewers found most interesting during the month of November: 1. Study Finds That Risk of ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 2, 2022 โ Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season ...
December 2, 2022 โ Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market ...
December 2, 2022 โ The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities ...
December 09, 2022
